Related Experiment Video
Updated: Jul 10, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta
Gidi Shani1, Wolfgang H Fischer, Nicholas J Justice
1Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA, 92037, USA.
Abstract:
Cripto is a multifunctional cell surface protein with important roles in vertebrate embryogenesis and the progression of human tumors. While Cripto has been shown to modulate multiple signaling pathways, its binding partners do not appear to fully explain its molecular actions. Therefore, we conducted a screen aimed at identifying novel Cripto-interacting proteins. This screen led to our identification of glucose-regulated protein 78 (GRP78), an endoplasmic reticulum (ER) chaperone that is also expressed at the surfaces of tumor cells. Here we demonstrate that Cripto and GRP78 interact at the cell surfaces of multiple cell lines and that their interaction is independent of prior association within the ER. Interestingly, short hairpin RNA knockdown of endogenous GRP78 resulted in enhanced transforming growth factor beta (TGF-beta) signaling, indicating that like Cripto, GRP78 inhibits this pathway. We further show that when coexpressed, GRP78 and Cripto collaborate to antagonize TGF-beta responses, including Smad phosphorylation and growth inhibition of prostate cancer cells grown under anchorage-dependent or -independent conditions. Finally, we provide evidence that cells coexpressing GRP78 and Cripto grow much more rapidly in soft agar than do cells expressing either protein individually. Together, our results indicate that these proteins bind at the cell surface to enhance tumor growth via the inhibition of TGF-beta signaling.
Insights
Cripto and glucose-regulated protein 78 (GRP78) interact on cell surfaces, inhibiting transforming growth factor beta (TGF-beta) signaling. This collaboration enhances tumor growth, particularly in prostate cancer cells.
Area of Science:
- Cell Biology
- Molecular Oncology
- Protein Interactions
Background:
- Cripto is a cell surface protein crucial for embryogenesis and tumor progression, modulating signaling pathways.
- Existing Cripto binding partners do not fully account for its molecular functions.
- Identification of novel Cripto-interacting proteins is necessary to elucidate its mechanisms.
Purpose of the Study:
- To identify novel proteins that interact with Cripto.
- To investigate the functional consequences of Cripto-GRP78 interaction.
- To determine the role of Cripto and GRP78 in transforming growth factor beta (TGF-beta) signaling and tumor growth.
Main Methods:
- Protein interaction screening to identify novel Cripto-binding partners.
- Cell surface co-immunoprecipitation assays to confirm Cripto-GRP78 interaction.
- Short hairpin RNA (shRNA) knockdown of GRP78 to assess TGF-beta signaling.
- Analysis of Smad phosphorylation and prostate cancer cell proliferation under various conditions.
- Soft agar assays to evaluate anchorage-independent growth.
Main Results:
- Glucose-regulated protein 78 (GRP78), an ER chaperone, was identified as a novel Cripto-interacting protein.
- Cripto and GRP78 interact at the cell surface, independent of ER association.
- GRP78 knockdown enhances TGF-beta signaling, indicating GRP78's inhibitory role.
- Coexpressed GRP78 and Cripto synergistically antagonize TGF-beta responses.
- Prostate cancer cells coexpressing GRP78 and Cripto exhibit significantly enhanced anchorage-independent growth.
Conclusions:
- Cripto and GRP78 form a cell surface complex that inhibits TGF-beta signaling.
- This interaction promotes tumor growth, particularly anchorage-independent proliferation.
- The Cripto-GRP78 complex represents a potential therapeutic target in cancer.
Related Concept Videos
TGF - β Signaling Pathway
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

